Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-03-24
2009-02-24
Goddard, Laura B (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07495073
ABSTRACT:
The present invention includes compositions including a novel short isoform of Annexin A10, termed Annexin 10s (ANXA10s) and methods of use. The compositions include nucleic acid molecules encoding ANXA10s, ANXA10s polypeptides, ANXA10s amino acid sequences and derivatives or modifications thereof. Included in these methods are the interrelation of the aberrant expressions of AFP, OPN, and the novel liver specific short isoform, ANXA10s, at human Chromosome 4q in the progression of hepatocellular carcinoma (HCC). The aberrant expressions of AFP, OPN and ANXA10s are shown to act cooperatively toward advanced disease, which could be useful for diagnostic, molecular staging or treatment of a patient having HCC or at risk of developing HCC.
REFERENCES:
GenBank, Accession No. AAT42216, Jun. 12, 2004, Peng et al, p. 1-2.
NCBI “Sequence Revision History”, 1page.
Bando K, Nagai H, Matsumoto S, Koyama M, Kawamura N, Onda M, Emi M: Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma.Genes Chromosomes Cancer1999, 25:284-289.
Behrend E I, Craig A M, Wioson S M, Denhardt D T, Chambers A F. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.Cancer Res1994;54:832-837.
Chou Y H, Chung K C, Jeng L B, Chen T C, Liaw Y F. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan.Cancer Lett1998; 123:1-6.
Deloukas P, et al. (>40 authors). A physical map of 30,000 human genes.Science1998, 282:744-746.
El-Tanani M, Barraclough R, Wilkinson M C, Rudland P S. Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor tcf-4.Cancer Res2001;61:5619-5629.
Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma.Pathol Int2002;52:19-24.
Guan X Y, Fang Y, Sham J S, Kwong D L, Zhang Y, Liang Q, Li H, Zhou H, Trent J M. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes ChromosomesCancer2000;29:110-116.
Hsu H C, Chiou T J, Chen Z Y, Lee C S, Lee P H, Peng S Y. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules.Hepatology1991;13:923-928.
Hsu H C, Jeng Y M, Mao T L, Chu J S, Lai P L, Peng S Y. β-Catenin mutations are associated with a subset of low stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.Am J Pathol2000;157:763-770.
Hsu H C, Wu T T, Wu M Z, Sheu J C, Lee C S, Chen D S. Tumor Invasiveness and prognosis in resected hepatocellular carcinoma: Clinical and pathogenetic implications.Cancer1988;61:2095-2099.
Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.J Hepatol2003;38:200-207.
Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.Hepatology1999;29:1858-1862.
Li M S, Li P F, He S P, Du G G, Li G. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma. Bel7402 cell line.World J Gastroenterol2002;8:469-475.
Li M S, Li P F, Yang F Y, He S P, Du G G, Li G. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells.Cell Res2002;12:151-156.
Li Y, Tang Z Y, Ye S L, Liu Y K, Chen J, Xue Q, Chen J, Gao D M, Bao W H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.World J Gastroenterol2001;7:630-636.
Liu S H, Lin C Y, Peng S Y, Jeng Y M, Pan H W, Cheng W, Kuo M Y P, Hsu H C. Down-regulation of Annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.Am J Pathol2002;160:1831-1837.
Ma X J, Salunga R, Tuggle J T, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang B M, Zhou Y X, Varnholt H, Smith B, Gadd M, Chatfield E, Kessler J, Baer T M, Erlander M G, Sgroi D C. Gene expression profiles of human breast cancer progression.Proc Natl Acad SciU S A. 2003;100:5974-5799.
Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.Genes Chromosomes Cancer1997;18:59-65.
McGowan-Jordan I J, Speevak M D, Blakey D, Cevrette M: Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4.Cancer Res1994, 54:2568-2572.
Medico E, Gentile A, Lo Celso C, Williams T A, Gambarotta G, Trusolino L, Comoglio P M. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.Cancer Res2001;61:5861-5868.
Morgan R O, Fernandez M P: Annexin gene structures and molecular evolutionary genetics.Cell Mol Life Sci1997, 53:508-515.
Morgan R O, Jenkins N A, Gilbert D J, Copeland N G, Balsara B R, Testa J R, Fernandez M P. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution.Genomics1999;60:40-49.
Moss S E, Morgan R O. The annexins.Genome Biol2004;5:219.1-219.8.
Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients.Cancer1989;64:1700-1707.
Pan H W, Ou Y H, Peng S Y, Liu S H, Lai P L, Lee P H, Sheu J C, Chen C L, Hsu H C. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.Cancer2003;98:119-127.
Peng S Y, Chen W J, Lai P L, Jeng Y M, Sheu J C, Hsu H C. High α-fetoprotein level with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis B virus infection, age, p53 and .beta.-catenin mutations.Int J Cancer2004; vol. 112 (in press).
Piao Z, Park C, Park J H, Kim H. Deletion mapping of chromosome 4q in hepatocellular carcinoma.Int J Cancer1998;79:356-360.
Tuck A B, Arsenault D M, O'Malley F P, Hota C, Ling M C, Wilson S M, Chambers A F. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.Oncogene1999;18:4237-4246.
van't Veer L J, Dai -H, van de Vijver M J, He Y D, Hart A A, Mao M, Peterse H L, van der Kooy K, Marton M J, Witteveen A T, Schreiber G J, Kerkhoven R M, Roberts C, Linsley P S, Bernards R, Friend S H. Gene expression profiling predicts clinical outcome of breast cancer.Nature2002;415:530-536.
Wang X W, Xu B. Stimulation of tumor-cell growth by alpha-fetoprotein.Int J Cancer1998;75:596-599.
Wong N, Lai P, Lee S W, Fan S, Pang E, Liew C T, Sheng Z, Lau J W, Johnson P J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.Am J Pathol1999;154:37-43.
Wong N, Lai P, Pang E, Fung L F, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S, Lau J W, Johnson P J. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.Clin Cancer Res2000;6:4000-4009.
Ye Q H, Qin L X, Forgues M, He P, Kim J W, Peng A C, Simon R, Li Y, Robles A I, Chen Y, Ma Z C, Wu Z Q, Ye S L, Liu Y K, Tang Z Y, Wang X W. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.Nat Med2003;9:416-423.
Zondervan P E, Wink J, Alers J C, IJzermans J N, Schalm S W, de Man R A, van Dekken H. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.J. Pathol2000;192:207-215.
Chen David C. P.
Hsu Hey-Chi
Asia Hepato Gene Company
Goddard Laura B
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Short isoform of Annexin A10 at chromosome 4q, termed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Short isoform of Annexin A10 at chromosome 4q, termed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short isoform of Annexin A10 at chromosome 4q, termed... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4094409